Empagliflozin is not expected to be effective in these populations
Effect of Gly-Gly-His, Gly-His-Lys and their copper complexes on TNF-alpha-dependent IL-6 secretion in normal human dermal fibroblasts
GLP-1 receptor agonist use was not associated with a substantially increased risk of thyroid cancer over a mean follow-up of 3.9 years, Bjrn Pasternak, MD, PhD, associate professor and principal researcher in the division of pharmacoepidemiology, department of medicine at Karolinska Institutet in Sweden, and colleagues wrote
Composite Endpoint Success The trials primary endpoint measured how many participants achieved both good blood sugar control (HbA1c below 7.0%) and meaningful weight loss (at least 10% reduction)
Thank you, I actually meant to say advisor, but yes, I'm glad you cleared that up
The short answer is no, not directly